Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1968 May;44(511):377–384. doi: 10.1136/pgmj.44.511.377

Thyroid and adrenal relationships

Victor Parsons, Ian Ramsay
PMCID: PMC2466598  PMID: 5655216

Abstract

A brief review of the actions of adrenal medullary and thyroid hormones is presented and the ways in which they interact are examined. It is concluded that thyroid hormone produces the necessary intracellular environment without which the steady state and emergency actions of cathecholamines would be vitiated. In hyperthyroidism the increased concentration of thyroid hormones results in a lowering of the threshold for catecholamine action. For this reason it is possible to alleviate many of the symptoms of thyrotoxicosis by means of drugs which block β-adrenergic receptors.

Attention is also drawn to the simultaneous occurrence of thyroid and adrenal disease, in the hope that this will encourage the search for further links in this field of endocrinology.

Full text

PDF
377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlquist R. P. Development of the concept of alpha and beta adrenotropic receptors. Ann N Y Acad Sci. 1967 Feb 10;139(3):549–552. doi: 10.1111/j.1749-6632.1967.tb41228.x. [DOI] [PubMed] [Google Scholar]
  2. BRAY G. A., GOODMAN H. M. STUDIES ON THE EARLY EFFECTS OF THYROID HORMONES. Endocrinology. 1965 Feb;76:323–328. doi: 10.1210/endo-76-2-323. [DOI] [PubMed] [Google Scholar]
  3. Blizzard R. M., Chee D., Davis W. The incidence of adrenal and other antibodies in the sera of patients with idiopathic adrenal insufficiency (Addison's disease). Clin Exp Immunol. 1967 Jan;2(1):19–30. [PMC free article] [PubMed] [Google Scholar]
  4. Blumenthal M., Davis R., Doe R. P. Carcinoid syndrome following reserpine therapy in thyrotoxicosis. Arch Intern Med. 1965 Dec;116(6):819–823. [PubMed] [Google Scholar]
  5. Bowness J. M. Epinephrine: cascade reactions and glycogenolytic effect. Science. 1966 Jun 3;152(3727):1370–1371. doi: 10.1126/science.152.3727.1370. [DOI] [PubMed] [Google Scholar]
  6. Bray G. A. Studies on the sensitivity to catecholamines after thyroidectomy. Endocrinology. 1966 Sep;79(3):554–564. doi: 10.1210/endo-79-3-554. [DOI] [PubMed] [Google Scholar]
  7. Brodie B. B., Davies J. I., Hynie S., Krishna G., Weiss B. Interrelationships of catecholamines with other endocrine systems. Pharmacol Rev. 1966 Mar;18(1):273–289. [PubMed] [Google Scholar]
  8. CANARY J. J., SCHAAF M., DUFFY B. J., Jr, KYLE L. H. Effects of oral and intramuscular administration of reserpine in thyrotoxicosis. N Engl J Med. 1957 Sep 5;257(10):435–442. doi: 10.1056/NEJM195709052571001. [DOI] [PubMed] [Google Scholar]
  9. CARPENTER C. C., SOLOMON N., SILVERBERG S. G., BLEDSOE T., NORTHCUTT R. C., KLINENBERG J. R., BENNETT I. L., Jr, HARVEY A. M. SCHMIDT'S SYNDROME (THYROID AND ADRENAL INSUFFICIENCY). A REVIEW OF THE LITERATURE AND A REPORT OF FIFTEEN NEW CASES INCLUDING TEN INSTANCES OF COEXISTENT DIABETES MELLITUS. Medicine (Baltimore) 1964 Mar;43:153–180. [PubMed] [Google Scholar]
  10. CHANCE B., HOLLUNGER G. Inhibition of electron and energy transfer in mitochondria. IV. Inhibition of energy-linked diphosphopyridine nucleotide reduction by uncoupling agents. J Biol Chem. 1963 Jan;238:445–448. [PubMed] [Google Scholar]
  11. Dewhurst W. G. On the chemical basis of mood. J Psychosom Res. 1965 Sep;9(1):115–127. doi: 10.1016/0022-3999(65)90020-6. [DOI] [PubMed] [Google Scholar]
  12. Doherty J. E., Perkins W. H. Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease. Ann Intern Med. 1966 Mar;64(3):489–507. doi: 10.7326/0003-4819-64-3-489. [DOI] [PubMed] [Google Scholar]
  13. ELLIS S. The metabolic effects of epinephrine and related amines. Pharmacol Rev. 1956 Dec;8(4):485–565. [PubMed] [Google Scholar]
  14. FELT V., SCHOVANEC B., BENES P., PLZAK F., VRBENSKY V. The effect of thyroid state, adrenaline and glucose on the release of free fatty acids form adipose tissue. Experientia. 1962 Aug 15;18:379–379. doi: 10.1007/BF02172262. [DOI] [PubMed] [Google Scholar]
  15. Furchgott R. F. The pharmacological differentiation of adrenergic receptors. Ann N Y Acad Sci. 1967 Feb 10;139(3):553–570. doi: 10.1111/j.1749-6632.1967.tb41229.x. [DOI] [PubMed] [Google Scholar]
  16. GAFFNEY T. E., BRAUNWALD E., KAHLER R. L. Effects of guanethidine on tri-iodothyronine-induced hyperthyroidism in man. N Engl J Med. 1961 Jul 6;265:16–20. doi: 10.1056/NEJM196107062650104. [DOI] [PubMed] [Google Scholar]
  17. GIFFORD R. W., Jr, KVALE W. F., MAHER F. T., ROTH G. M., PRIESTLEY J. T. CLINICAL FEATURES, DIAGNOSIS AND TREATMENT OF PHEOCHROMOCYTOMA: A REVIEW OF 76 CASES. Mayo Clin Proc. 1964 Apr;39:281–302. [PubMed] [Google Scholar]
  18. GLUSHIEN A. S., MANSUY M. M., LITTMAN D. S. Pheochromocytoma; its relationship to the neurocutaneous syndromes. Am J Med. 1953 Mar;14(3):318–327. doi: 10.1016/0002-9343(53)90043-6. [DOI] [PubMed] [Google Scholar]
  19. GRAHAM J. B. Pheochromocytoma and hypertension; an analysis of 207 cases. Int Abstr Surg. 1951 Feb;92(2):105–121. [PubMed] [Google Scholar]
  20. GREEN K., MATTY A. J. Action of thyroxine on active transport in isolated membranes of Bufo bufo. Gen Comp Endocrinol. 1963 Jun;3:244–252. doi: 10.1016/0016-6480(63)90019-4. [DOI] [PubMed] [Google Scholar]
  21. HARRISON T. S. ADRENAL MEDULLARY AND THYROID RELATIONSHIPS. Physiol Rev. 1964 Apr;44:161–185. doi: 10.1152/physrev.1964.44.2.161. [DOI] [PubMed] [Google Scholar]
  22. HARRISON T. S. Reflex liberation of catechol hormones in hyperthyroidism. J Surg Res. 1961 May;1:77–81. doi: 10.1016/s0022-4804(61)80026-7. [DOI] [PubMed] [Google Scholar]
  23. HOCH F. L. Thyrotoxicosis as a disease of mitochondria. N Engl J Med. 1962 Mar 8;266:498–concl. doi: 10.1056/NEJM196203082661007. [DOI] [PubMed] [Google Scholar]
  24. Harrison T. S., Siegel J. H., Wilson W. S., Weber W. J. Adrenergic reactivity in hyperthyroidism. Arch Surg. 1967 Mar;94(3):396–402. doi: 10.1001/archsurg.1967.01330090090023. [DOI] [PubMed] [Google Scholar]
  25. Himms-Hagen J. Sympathetic regulation of metabolism. Pharmacol Rev. 1967 Sep;19(3):367–461. [PubMed] [Google Scholar]
  26. Hoch F. L. Biochemistry of hyperthyroidism and hypothyroidism. Postgrad Med J. 1968 May;44(511):347–362. doi: 10.1136/pgmj.44.511.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hornbrook K. R., Quinn P. V., Siegel J. H., Brody T. M. Thyroid hormone regulation of cardiac glycogen metabolism. Biochem Pharmacol. 1965 Jun;14(6):925–936. doi: 10.1016/0006-2952(65)90244-3. [DOI] [PubMed] [Google Scholar]
  28. Irvine W. J., Stewart A. G., Scarth L. A clinical and immunological study of adrenocortical insufficiency (Addison's disease). Clin Exp Immunol. 1967 Jan;2(1):31–70. [PMC free article] [PubMed] [Google Scholar]
  29. Johansson H. Gastrointestinal motility function related to thyroid activity. An experimental study in the rat. Acta Chir Scand Suppl. 1966;359:1–88. [PubMed] [Google Scholar]
  30. KOCH-WESER J., BLINKS J. R. THE INFLUENCE OF THE INTERVAL BETWEEN BEATS ON MYOCARDIAL CONTRACTILITY. Pharmacol Rev. 1963 Sep;15:601–652. [PubMed] [Google Scholar]
  31. LEAK D. Adrenergic blockade and thyrotoxicosis. Acta Endocrinol (Copenh) 1963 May;43:131–136. doi: 10.1530/acta.0.0430131. [DOI] [PubMed] [Google Scholar]
  32. LEAK D., BRUNJES S., JOHNS V. J., Jr, STARR P. LETTER TO THE EDITOR: EXCESS THYROID MEDICATION AND ADRENAL MEDULLARY RESPONSE TO INSULIN HYPOGLYCEMIA. J Clin Endocrinol Metab. 1963 Aug;23:834–836. doi: 10.1210/jcem-23-8-834. [DOI] [PubMed] [Google Scholar]
  33. LEE W. Y., BRONSKY D., WALDSTEIN S. S. Studies of thyroid and sympathetic nervous system interrelationships. II. Effects of guanethidine on manifestations of hyperthyroidism. J Clin Endocrinol Metab. 1962 Sep;22:879–885. doi: 10.1210/jcem-22-9-879. [DOI] [PubMed] [Google Scholar]
  34. MORALES AGUILERA A., VAUGHANWILLIAMS E. M. THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS. Br J Pharmacol Chemother. 1965 Apr;24:332–338. doi: 10.1111/j.1476-5381.1965.tb01719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Marsden C. D., Gimlette T. M., McAllister R. G., Owen D. A., Miller T. N. Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients. Acta Endocrinol (Copenh) 1968 Mar;57(3):353–362. doi: 10.1530/acta.0.0570353. [DOI] [PubMed] [Google Scholar]
  36. Mayer S. E., Williams B. J., Smith J. M. Adrenergic mechanisms in cardiac glycogen metabolism. Ann N Y Acad Sci. 1967 Feb 10;139(3):686–702. doi: 10.1111/j.1749-6632.1967.tb41238.x. [DOI] [PubMed] [Google Scholar]
  37. Parsons V., Jewitt D. Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias. Postgrad Med J. 1967 Dec;43(506):756–762. doi: 10.1136/pgmj.43.506.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. RIZACK M. A. ACTIVATION OF AN EPINEPHRINE-SENSITIVE LIPOLYTIC ACTIVITY FROM ADIPOSE TISSUE BY ADENOSINE 3',5'-PHOSPHATE. J Biol Chem. 1964 Feb;239:392–395. [PubMed] [Google Scholar]
  39. ROITT I. M., DONIACH D. Thyroid auto-immunity. Br Med Bull. 1960 May;16:152–158. doi: 10.1093/oxfordjournals.bmb.a069816. [DOI] [PubMed] [Google Scholar]
  40. Ramsay I. D. Muscle dysfunction in hyperthyroidism. Lancet. 1966 Oct 29;2(7470):931–934. doi: 10.1016/s0140-6736(66)90536-8. [DOI] [PubMed] [Google Scholar]
  41. Robillard M., Klotz B., Perrault M. L'inhibition des récepteurs bèta-adrénergiques dans le traitement de la maladie de Basedow. Presse Med. 1967 Apr 15;75(18):897–900. [PubMed] [Google Scholar]
  42. Sneddon J. M., Turner P. Adrenergic blockade and the eye signs of thyrotoxicosis. Lancet. 1966 Sep 3;2(7462):525–527. doi: 10.1016/s0140-6736(66)92881-9. [DOI] [PubMed] [Google Scholar]
  43. Sutherland E. W., Robison G. A. The role of cyclic-3',5'-AMP in responses to catecholamines and other hormones. Pharmacol Rev. 1966 Mar;18(1):145–161. [PubMed] [Google Scholar]
  44. TAPLEY D. F. MODE AND SITE OF ACTION OF THYROXINE. Mayo Clin Proc. 1964 Aug;39:626–636. [PubMed] [Google Scholar]
  45. TATA J. R., ERNSTER L., LINDBERG O., ARRHENIUS E., PEDERSEN S., HEDMAN R. The action of thyroid hormones at the cell level. Biochem J. 1963 Mar;86:408–428. doi: 10.1042/bj0860408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Turner P., Granville-Grossman K. L. Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Lancet. 1965 Dec 25;2(7426):1316–1318. doi: 10.1016/s0140-6736(65)92340-8. [DOI] [PubMed] [Google Scholar]
  47. Urbanski F. X. Medullary thyroid carcinoma, parathyroid adenoma, and bilateral pheochromocytoma. An unusual triad of endocrine tumors. J Chronic Dis. 1967 Aug;20(8):627–636. doi: 10.1016/0021-9681(67)90040-9. [DOI] [PubMed] [Google Scholar]
  48. WILLIAMS E. D. A REVIEW OF 17 CASES OF CARCINOMA OF THE THYROID AND PHAEOCHROMOCYTOMA. J Clin Pathol. 1965 May;18:288–292. doi: 10.1136/jcp.18.3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. WISWELL J. G., HURWITZ G. E., CORONHO V., BING O. H., CHILD D. L. URINARY CATECHOL AMINES AND THEIR METABOLITES IN HYPERTHYROIDISM AND HYPOTHYROIDISM. J Clin Endocrinol Metab. 1963 Nov;23:1102–1106. doi: 10.1210/jcem-23-11-1102. [DOI] [PubMed] [Google Scholar]
  50. WOOLNER L. B., BEAHRS O. H., BLACK B. M., McCONAHEY W. M., KEATING F. R., Jr Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period. Am J Surg. 1961 Sep;102:354–387. doi: 10.1016/0002-9610(61)90527-x. [DOI] [PubMed] [Google Scholar]
  51. Waldstein S. S. Thyroid-catecholamine interrelations. Annu Rev Med. 1966;17:123–132. doi: 10.1146/annurev.me.17.020166.001011. [DOI] [PubMed] [Google Scholar]
  52. Williams E. D., Pollock D. J. Multiple mucosal neuromata with endocrine tumours: a syndrome allied to von Recklinghausen's disease. J Pathol Bacteriol. 1966 Jan;91(1):71–80. doi: 10.1002/path.1700910109. [DOI] [PubMed] [Google Scholar]
  53. Williamson J. R. Metabolic effects of epinephrine in the perfused rat heart. II. Control steps of glucose and glycogen metabolism. Mol Pharmacol. 1966 May;2(3):206–220. [PubMed] [Google Scholar]
  54. Wilson W. R., Theilen E. O., Hege J. H., Valenca M. R. Effects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism. J Clin Invest. 1966 Jul;45(7):1159–1169. doi: 10.1172/JCI105422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. el Kabir D. J., Benhamou-Glynn N., Doniach D., Roitt I. M. Absorption of thyroid-stimulating globulin from thyrotoxic sera by organ homogenates. Nature. 1966 Apr 16;210(5033):319–321. doi: 10.1038/210319a0. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES